CSI Market
Sign In | Register

Taro Pharmaceutical Industries Ltd (TARO) Annual Balance Sheets

Annual · GAAP · USD millions
Access TARO quarterly Balance Sheets →
Balance sheet data covering Taro Pharmaceutical Industries Ltd–Mar 31 2019 offers a view into how Mar 31 2023's financial position has changed alongside business activity.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Mar 31 2023)
(Mar 31 2022) (Mar 31 2021) (Mar 31 2020) (Mar 31 2019)
Assets
Cash & cash equivalent154.50
Marketable Securities, Current SH2.46
Other Short-term Investments120.00
Cash & Short-term Investments276.00
Accounts receivable458.22
Other Receivables13.13
Notes Receivable, Current1.85
Inventories117.99
Other Current Assets177.19
Total loans net11.72
Total Current Assets1,336.43
Equipment/Property/Plant Net331.58
Goodwill net17.23
Intangible Assets82.15
Long-term investments404.90
Deferred Tax Assets, Net of Valuation Allowance, Noncurrent17.57
Prepaid Expense and Other Assets, Total1.01
Other Assets, Noncurrent28.00
Short Term Bank Deposits0.00
Short Term And Current Maturities Of Long Term Bank Deposit119.98
Deferred Income Tax Assets Net103.67
Total Assets2,135.51
Liabilities
Accounts Payable, Trade, Current3.65
Accrued Liabilities, Current23.95
Financial Instruments3.55
Other Liabilities, Current237.05
Accrued Income Taxes, Current TA33.01
Total Current Liabilities385.55
Total Long-term Debt0.00
Employee Benefit Plans, Noncurrent5.12
Deferred credits, Noncurrent9.57
Deferred Tax Liabilities, Net, Noncurrent LI5.35
Other liabilities, Noncurrent19.11
Medicaid And Indirect Rebates22.40
Deferred Income Tax Liabilities Net-
Total Liabilities404.65
Stockholders' Equity
Founders Shares Value0.00
Common Stock Value0.68
Treasury Stock Value771.41
Additional Paid In Capital Common Stock262.45
Retained Earnings / Accumulated Deficit2,414.14
Accumulated Other Comprehensive Income-12.67
Other Equity-175.00
Common Stockholder's Equity1,730.86
Non-controlling interests & other0.00
Total Stockholder's Equity1,730.86
Liabilities & Stockholder's Equity2,135.51
4 historic quarters locked

Sign in to unlock the full Taro Pharmaceutical Industries Ltd balance sheet history.

Sign In Create Free Account

About Taro Pharmaceutical Industries Ltd Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0000950170-23-030778

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License